Glenmark Combiwave FB 200 Inhaler - 150D

Glenmark Combiwave FB 200 Inhaler - 150D

Category: Drug Info

Specifications
Details

Product Overview

  • Active Ingredients: Salmeterol Xinafoate 25 mcg and Fluticasone Propionate 125 mcg per actuation

  • Manufacturer: Glenmark Pharmaceuticals Ltd.

  • Registration Number (MAL): MAL14055154AZ

Indications

  • Management of asthma in patients aged 12 years and older

  • Treatment of chronic obstructive pulmonary disease (COPD)

  • Prevention of bronchospasm and reduction of inflammation in the airways

Instructions for Use

  • Shake the inhaler well before each use

  • Hold the inhaler upright, exhale fully, place the mouthpiece between your teeth without biting, and form a good seal with your lips

  • Breathe in slowly and deeply through your mouth while pressing down firmly on the canister to release a dose

  • Hold your breath for 5–10 seconds, then breathe out gently

  • Repeat the above steps if a second dose is prescribed

  • Replace the cover after use

  • Rinse your mouth with water after each use to reduce the risk of oral thrush


View more about Glenmark Combiwave FB 200 Inhaler - 150D on main site